Literature DB >> 8936332

The human/sheep xenograft model: a large animal model of human hematopoiesis.

E D Zanjani1, G Almeida-Porada, A W Flake.   

Abstract

Although not 'ideal', xenograft models of human hematopoiesis have proved to be extremely useful experimental systems for the study of the in vivo engraftment/proliferation potential of human hematopoietic stem/progenitor cells (HSC). Among these, the human/sheep xenograft model is unique in several respects. This model takes advantage of fetal immunologic immaturity and developing 'homing' spaces in the fetal bone marrow to obtain donor HSC engraftment in normal recipients without marrow conditioning. This avoids both the possible stromal abnormalities associated with irradiation- and/or chemotherapy-induced immunodeficiency which may limit human HSC engraftment or long-term maintenance of human hematopoiesis, and the use of genetically deficient hosts which may result in restricted donor cell expression. In the human/sheep xenograft model, human HSC (1) colonizes the bone marrow, (2) persists for many years, (3) is capable of multilineage differentiation, (4) retains its ability to respond to human cytokines, and (5) retains its ability to engraft/differentiate in secondary recipients. Another unique aspect of the sheep model is its large size; this permits repeated evaluation of human cell activity in the same chimeric sheep over long periods. The model appears to discriminate between the different populations of human HSC and exhibits a degree of sensitivity that suggests this in utero approach may serve as a biologically relevant model for the identification, characterization, and study of the in vivo potential of human HSC from available sources.

Entities:  

Mesh:

Year:  1996        PMID: 8936332     DOI: 10.1016/0925-5710(96)00445-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

Review 1.  Hematopoietic stem cells.

Authors:  Robert G Hawley; Ali Ramezani; Teresa S Hawley
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 2.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

3.  The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.

Authors:  B Tong; H L Grimes; T Y Yang; S E Bear; Z Qin; K Du; W S El-Deiry; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Update of humanized animal disease models in studying Graft-versus-host disease.

Authors:  Feng Huang; Feng Lin Cao; Song Guo Zheng
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

5.  Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes.

Authors:  M Lee Lucas; Nancy E Seidel; Christopher D Porada; John G Quigley; Stacie M Anderson; Harry L Malech; Janis L Abkowitz; Esmail D Zanjani; David M Bodine
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

6.  Temporal definition of haematopoietic stem cell niches in a large animal model of in utero stem cell transplantation.

Authors:  Christine Jeanblanc; Angelina Daisy Goodrich; Evan Colletti; Saloomeh Mokhtari; Christopher D Porada; Esmail D Zanjani; Graça Almeida-Porada
Journal:  Br J Haematol       Date:  2014-03-27       Impact factor: 6.998

7.  Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice.

Authors:  Christopher J Hogan; Elizabeth J Shpall; Gordon Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

8.  Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.

Authors:  Christopher D Porada; Chad Sanada; Chung-Jung Kuo; Evan Colletti; Walter Mandeville; John Hasenau; Esmail D Zanjani; Robert Moot; Christopher Doering; H Trent Spencer; Graça Almeida-Porada
Journal:  Exp Hematol       Date:  2011-09-08       Impact factor: 3.084

Review 9.  Bone marrow stem cells and liver regeneration.

Authors:  Graça Almeida-Porada; Esmail D Zanjani; Christopher D Porada
Journal:  Exp Hematol       Date:  2010-04-24       Impact factor: 3.084

10.  Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells.

Authors:  Christopher D Porada; Duygu D Harrison-Findik; Chad Sanada; Vincent Valiente; David Thain; Paul J Simmons; Graça Almeida-Porada; Esmail D Zanjani
Journal:  Exp Hematol       Date:  2008-12       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.